Single Intravenous Dose Dalbavancin Pathway for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Considerations for Emergency Department Implementation and Cost Savings

• Frank LoVecchioArizona State University
• Matthew William McCarthyNewYork–Presbyterian Hospital
• Xiaolan YeAbbVie (United States)
• Alasdair D. Henry
• Quan V. Doan
• John L. LockAbbVie (United States)
• Todd A. RiccobeneAbbVie (United States)
• Rosie D. LylesAbbVie (United States)
• David A. TalanUniversity of California, Los Angeles